Akebia Ther Stock Probability of Future Stock Price Finishing Over 1.34
| AKBA Stock | USD 2.04 0.09 4.23% |
Akebia |
Akebia Ther Target Price Odds to finish over 1.34
The tendency of Akebia Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 1.34 in 90 days |
| 2.04 | 90 days | 1.34 | about 81.3 |
Based on a normal probability distribution, the odds of Akebia Ther to stay above $ 1.34 in 90 days from now is about 81.3 (This Akebia Ther probability density function shows the probability of Akebia Stock to fall within a particular range of prices over 90 days) . Probability of Akebia Ther price to stay between $ 1.34 and its current price of $2.04 at the end of the 90-day period is about 76.87 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.82 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Akebia Ther will likely underperform. Additionally Akebia Ther has an alpha of 0.2927, implying that it can generate a 0.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Akebia Ther Price Density |
| Price |
Predictive Modules for Akebia Ther
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Akebia Ther. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Akebia Ther Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Akebia Ther is not an exception. The market had few large corrections towards the Akebia Ther's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Akebia Ther, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Akebia Ther within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.29 | |
β | Beta against Dow Jones | 1.82 | |
σ | Overall volatility | 0.27 | |
Ir | Information ratio | 0.1 |
Akebia Ther Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Akebia Ther for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Akebia Ther can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Akebia Ther appears to be risky and price may revert if volatility continues | |
| Akebia Ther has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 194.62 M. Net Loss for the year was (51.92 M) with profit before overhead, payroll, taxes, and interest of 140.04 M. | |
| Akebia Ther currently holds about 143.89 M in cash with (23.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78. | |
| Akebia Ther has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 |
Akebia Ther Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Akebia Stock often depends not only on the future outlook of the current and potential Akebia Ther's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Akebia Ther's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 187.5 M | |
| Cash And Short Term Investments | 42.9 M |
Akebia Ther Technical Analysis
Akebia Ther's future price can be derived by breaking down and analyzing its technical indicators over time. Akebia Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Akebia Ther. In general, you should focus on analyzing Akebia Stock price patterns and their correlations with different microeconomic environments and drivers.
Akebia Ther Predictive Forecast Models
Akebia Ther's time-series forecasting models is one of many Akebia Ther's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Akebia Ther's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Akebia Ther
Checking the ongoing alerts about Akebia Ther for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Akebia Ther help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Akebia Ther appears to be risky and price may revert if volatility continues | |
| Akebia Ther has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 194.62 M. Net Loss for the year was (51.92 M) with profit before overhead, payroll, taxes, and interest of 140.04 M. | |
| Akebia Ther currently holds about 143.89 M in cash with (23.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78. | |
| Akebia Ther has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 |
Check out Akebia Ther Backtesting, Akebia Ther Valuation, Akebia Ther Correlation, Akebia Ther Hype Analysis, Akebia Ther Volatility, Akebia Ther History as well as Akebia Ther Performance. For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akebia Ther. If investors know Akebia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akebia Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.22) | Revenue Per Share 0.834 | Quarterly Revenue Growth (0.11) | Return On Assets (0.09) | Return On Equity (5.53) |
The market value of Akebia Ther is measured differently than its book value, which is the value of Akebia that is recorded on the company's balance sheet. Investors also form their own opinion of Akebia Ther's value that differs from its market value or its book value, called intrinsic value, which is Akebia Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akebia Ther's market value can be influenced by many factors that don't directly affect Akebia Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akebia Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akebia Ther is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akebia Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.